(PDF) Corrigendum to “Healthcare Costs of the SATisfaction

Corrigendum to “Healthcare Costs of the SATisfaction and Adherence to COPD Treatment (SAT) Study Follow-Up” [Respir. Med. 153 (2019) 68–75]

Respiratory Medicine - United Kingdom

doi 10.1016/j.rmed.2019.06.009

Full Text

Open PDF

Abstract

Available in full text

Date

November 1, 2019

Authors

Publisher

Elsevier BV

Related search

Healthcare Costs Attributable to the Treatment of Patients With Spinal Metastases: A Cohort Study With Up to 8 Years Follow-Up

English

Correction to Lancet Respir Med 2019; 7: 46–59

Lancet Respiratory Medicine,The

Pulmonary

Respiratory Medicine

2019

English

Adherence to Follow-Up Recommendations in Asthma

English

Adherence to Recommendations for Follow-Up to Abnormal Pap Tests

Obstetrics and Gynecology

Gynecology

Obstetrics

2007

English

Corrigendum to “Fluticasone Furoate/Vilanterol (100/25; 200/25 Μg) Improves Lung Function in COPD: A Randomised Trial” [Respir Med 107 (2013) 550–559]

English

Prs23 - Persistence to Copd Therapies and Impact on Costs Related to Healthcare Consumption: A French Claims Data Study

English

Corrigendum to “A Randomised Trial of Fluticasone Furoate/Vilanterol (50/25 Μg; 100/25 Μg) on Lung Function in COPD” [Respir Med, 107 (2013) 560–569]

English

Automated Telecommunication to Obtain Longitudinal Follow-Up in a Multicenter Cross-Sectional COPD Study

COPD: Journal of Chronic Obstructive Pulmonary Disease

English

Corrigendum to “Factors Associated With Pulmonary Hypertension and Long-Term Survival in Bronchiectasis Subjects” [Respir. Med. (2016) 119 109–114]

English

Amanote Research

Corrigendum to “Healthcare Costs of the SATisfaction and Adherence to COPD Treatment (SAT) Study Follow-Up” [Respir. Med. 153 (2019) 68–75]

Respiratory Medicine - United Kingdom

doi 10.1016/j.rmed.2019.06.009

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Healthcare Costs Attributable to the Treatment of Patients With Spinal Metastases: A Cohort Study With Up to 8 Years Follow-Up

Correction to Lancet Respir Med 2019; 7: 46–59

Adherence to Follow-Up Recommendations in Asthma

Adherence to Recommendations for Follow-Up to Abnormal Pap Tests

Corrigendum to “Fluticasone Furoate/Vilanterol (100/25; 200/25 Μg) Improves Lung Function in COPD: A Randomised Trial” [Respir Med 107 (2013) 550–559]

Prs23 - Persistence to Copd Therapies and Impact on Costs Related to Healthcare Consumption: A French Claims Data Study

Corrigendum to “A Randomised Trial of Fluticasone Furoate/Vilanterol (50/25 Μg; 100/25 Μg) on Lung Function in COPD” [Respir Med, 107 (2013) 560–569]

Automated Telecommunication to Obtain Longitudinal Follow-Up in a Multicenter Cross-Sectional COPD Study

Corrigendum to “Factors Associated With Pulmonary Hypertension and Long-Term Survival in Bronchiectasis Subjects” [Respir. Med. (2016) 119 109–114]